Your session is about to expire
← Back to Search
Hyperbaric Oxygen Therapy for Aging (HBOT Trial)
HBOT Trial Summary
This trial will test whether hyperbaric oxygen therapy can help improve epigenetic aging, inflammation, and cellular health.
HBOT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 2 trial • 20 Patients • NCT02363959HBOT Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Could you give an estimate of how many individuals are taking part in this research project?
"That is correct. The clinical trial in question, which was first advertised on March 1st, is still recruiting patients. As of right now, they are looking for 30 individuals to take part in the study that is being conducted across a single location."
Who meets the screening criteria to take part in this research project?
"Up to 30 patients, of any sex, gender orientation or ethnicity, who are currently experiencing the effects of aging and meet the other inclusion criteria listed below, may participate in this study. Ages 40-70 Any sex, gender orientation and ethnicity Must be willing and able to participate in venipuncture, health history and clinical assessments, lab test assessment, hyperbaric oxygen treatment. Participants must also agree to maintain their current lifestyle choices consistent with pre- participation with this study. This means that participants should not change their exercise programs, diets, sleep patterns supplements or other habits without reporting these changes to staff."
Is this particular clinical trial testing for individuals outside of the 55+ age demographic?
"The age requirements for this clinical trial are a minimum of 40 years old and a maximum of 70 years old."
Are people with this condition still able to enroll in the research program?
"That is accurate. Information available on clinicaltrials.gov reveals that this trial, which was first advertised on March 1st 2022, is still recruiting patients. They need approximately 30 individuals from 1 locations."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Most responsive sites:
- New Jersey HBOT: < 48 hours
Average response time
- < 2 Days
Typically responds via
Share this study with friends
Copy Link
Messenger